These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15302187)

  • 1. Arguments for live flavivirus vaccines.
    Murphy BR; Blaney JE; Whitehead SS
    Lancet; 2004 Aug 7-13; 364(9433):499-500. PubMed ID: 15302187
    [No Abstract]   [Full Text] [Related]  

  • 2. Arguments for live flavivirus vaccines.
    Hombach J; Kurane I; Wood D
    Lancet; 2004 Aug 7-13; 364(9433):498-9. PubMed ID: 15302184
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety concerns with regard to live attenuated flavivirus vaccines.
    Seligman SJ; Gould EA
    J Infect Dis; 2008 Sep; 198(5):794-5. PubMed ID: 18694340
    [No Abstract]   [Full Text] [Related]  

  • 4. Arguments for live flavivirus vaccines.
    de Silva A; Messer W
    Lancet; 2004 Aug 7-13; 364(9433):500. PubMed ID: 15302188
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral emergence and immune interplay in flavivirus vaccines.
    Fischer C; de Oliveira-Filho EF; Drexler JF
    Lancet Infect Dis; 2020 Jan; 20(1):15-17. PubMed ID: 31876486
    [No Abstract]   [Full Text] [Related]  

  • 6. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the RepliVax platform for replication-defective flavivirus vaccines.
    Rumyantsev AA; Giel-Moloney M; Liu Y; Gao QS; Zhang ZX; Catalan J; Frolov I; Almond J; Kleanthous H; Pugachev KV
    Vaccine; 2011 Jul; 29(32):5184-94. PubMed ID: 21620917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live virus vaccines for use in animals.
    Bostock CJ
    Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966
    [No Abstract]   [Full Text] [Related]  

  • 9. Mimicking live flavivirus immunization with a noninfectious RNA vaccine.
    Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a live attenuated vaccine candidate against duck Tembusu viral disease.
    Li G; Gao X; Xiao Y; Liu S; Peng S; Li X; Shi Y; Zhang Y; Yu L; Wu X; Yan P; Yan L; Teng Q; Tong G; Li Z
    Virology; 2014 Feb; 450-451():233-42. PubMed ID: 24503086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency control of modified live viral vaccines for veterinary use.
    Terpstra C; Kroese AH
    Vaccine; 1996 Jan; 14(1):13-8. PubMed ID: 8821643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
    Pugachev KV; Schwaiger J; Brown N; Zhang ZX; Catalan J; Mitchell FS; Ocran SW; Rumyantsev AA; Khromykh AA; Monath TP; Guirakhoo F
    Vaccine; 2007 Sep; 25(37-38):6661-71. PubMed ID: 17693000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected lack of efficacy of a live IBR marker vaccine in two dairy herds.
    Allcock J; May B; Wright T; Otter A
    Vet Rec; 2010 Nov; 167(19):759-60. PubMed ID: 21257515
    [No Abstract]   [Full Text] [Related]  

  • 15. The neurovirulence of flaviviruses in crab-eating monkeys (Macaca fascicularis).
    Angsubhakorn S; Moe JB; Latendresse JR; Ward GS; Ngamprochana M; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):604-12. PubMed ID: 3033834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Langat E5 virus as a live virus vaccine against Kyasanur Forest disease virus.
    Thind IS
    Indian J Med Res; 1981 Feb; 73():141-9. PubMed ID: 6263797
    [No Abstract]   [Full Text] [Related]  

  • 18. Flavivirus DNA vaccines--good science, uncertain future.
    Petersen LR; Roehrig JT
    J Infect Dis; 2007 Dec; 196(12):1721-3. PubMed ID: 18190248
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early summer meningoencephalitis vaccination. The indications and a critical assessment of the neurological vaccination complications].
    Gold R; Wiethölter H; Rihs I; Löwer J; Kappos L
    Dtsch Med Wochenschr; 1992 Jan; 117(3):112-6. PubMed ID: 1309694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.